Risk of harm from use of sodium-glucose co-transporter-2 (SGLT-2) inhibitors in patients pre or post bariatric surgery

Mitesh Sharma, Rahul Nayar, Yitka Graham, Helen M Parretti, Sally Abbott, Abd Tahrani, Alexander D Miras, Brijesh Madhok, Rishi Singhal, Kamal Mahawar

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish
Pages (from-to)2469-2470
Number of pages2
JournalObesity surgery
Volume32
Issue number7
Early online date28 Apr 2022
DOIs
Publication statusPublished - Jul 2022

Keywords

  • Bariatric Surgery/adverse effects
  • Diabetes Mellitus, Type 2/drug therapy
  • Glucose
  • Humans
  • Hypoglycemic Agents
  • Obesity, Morbid/surgery
  • Sodium
  • Sodium-Glucose Transporter 2
  • Sodium-Glucose Transporter 2 Inhibitors/adverse effects

Cite this